Craneware plc (CRWRF)
- Previous Close
23.00 - Open
23.86 - Bid 23.64 x 40000
- Ask 28.61 x --
- Day's Range
23.86 - 23.86 - 52 Week Range
19.01 - 30.00 - Volume
2,283 - Avg. Volume
12 - Market Cap (intraday)
843.277M - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
72.30 - EPS (TTM)
0.33 - Earnings Date Sep 3, 2024
- Forward Dividend & Yield 0.37 (1.37%)
- Ex-Dividend Date Nov 29, 2024
- 1y Target Est
--
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, it offers appeal, professional, and pharmacy professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.
www.thecranewaregroup.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: CRWRF
View MorePerformance Overview: CRWRF
Trailing total returns as of 10/10/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRWRF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRWRF
View MoreValuation Measures
Market Cap
920.89M
Enterprise Value
926.45M
Trailing P/E
81.93
Forward P/E
25.77
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.07
Price/Book (mrq)
2.93
Enterprise Value/Revenue
4.89
Enterprise Value/EBITDA
17.07
Financial Highlights
Profitability and Income Statement
Profit Margin
6.18%
Return on Assets (ttm)
2.28%
Return on Equity (ttm)
3.57%
Revenue (ttm)
189.27M
Net Income Avi to Common (ttm)
11.7M
Diluted EPS (ttm)
0.33
Balance Sheet and Cash Flow
Total Cash (mrq)
34.59M
Total Debt/Equity (mrq)
12.22%
Levered Free Cash Flow (ttm)
29.07M
Company Insights: CRWRF
CRWRF does not have Company Insights